These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 39048301)

  • 1. Genotype Analysis of Respiratory Syncytial Virus Before and After the COVID-19 Pandemic Using Whole-Genome Sequencing: A Prospective, Single-Center Study in Korea From 2019 to 2022.
    Na B; Park YJ; Seo J; Park M; Baek JY; Lee JY; Kim M; Ahn JG; Lee ST; Kang JM
    J Korean Med Sci; 2024 Jul; 39(28):e206. PubMed ID: 39048301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of respiratory syncytial virus fusion protein from clinical isolates of Korean children in palivizumab era, 2009-2015.
    Choi SH; Park KS; Kim YJ
    J Infect Chemother; 2019 Jul; 25(7):514-519. PubMed ID: 30885457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome molecular analysis of respiratory syncytial virus pre and during the COVID-19 pandemic in Free State province, South Africa.
    Sondlane H; Ogunbayo A; Donato C; Mogotsi M; Esona M; Hallbauer U; Bester P; Goedhals D; Nyaga M
    Virus Res; 2024 Sep; 347():199421. PubMed ID: 38942296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab (MEDLEY).
    Tuffy KM; Ahani B; Domachowske JB; Furuno K; Ji H; Madhi SA; Mankad VS; Hamrén UW; Villafana T; Wang Y; Kelly EJ; Wilkins D
    Vaccine; 2024 Oct; 42(24):126276. PubMed ID: 39241352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of ON1 and novel genotypes of human respiratory syncytial virus and emergence of palivizumab resistance in Lebanon.
    Abou-El-Hassan H; Massaad E; Soudani N; Assaf-Casals A; Shaker R; Lteif Khoury M; Ghanem S; Karam M; Andary R; Saito R; Dbaibo G; Zaraket H
    PLoS One; 2019; 14(2):e0212687. PubMed ID: 30789963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic characterization of circulating human respiratory syncytial viruses A and B in Kuwait using whole-genome sequencing.
    Madi N; Safar HA; Al-Adwani A; Sadeq M; Al-Turab M
    Microbiol Spectr; 2024 Jul; 12(7):e0015924. PubMed ID: 38808977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 Pandemic Restrictions on Respiratory Virus Patterns: Insights from RSV Surveillance in Gwangju, South Korea.
    Cho SJ; Kim SH; Mun J; Yun JE; Park S; Park J; Lee YU; Park JS; Yun H; Lee CM; Kim JP; Seo JM
    Viruses; 2024 May; 16(6):. PubMed ID: 38932143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic evolution of human respiratory syncytial virus during a decade (2013-2023): bridging the path to monoclonal antibody surveillance.
    Piñana M; González-Sánchez A; Andrés C; Vila J; Creus-Costa A; Prats-Méndez I; Arnedo-Muñoz M; Saubi N; Esperalba J; Rando A; Nadal-Baron P; Quer J; González-López JJ; Soler-Palacín P; Martínez-Urtaza J; Larrosa N; Pumarola T; Antón A
    J Infect; 2024 May; 88(5):106153. PubMed ID: 38588960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of respiratory syncytial viruses infecting children reported to have received palivizumab immunoprophylaxis.
    Oliveira DB; Iwane MK; Prill MM; Weinberg GA; Williams JV; Griffin MR; Szilagyi PG; Edwards KM; Staat MA; Hall CB; Durigon EL; Erdman DD
    J Clin Virol; 2015 Apr; 65():26-31. PubMed ID: 25766983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic characterization of respiratory syncytial virus surface glycoproteins F and G in Taiwan, 2017-2021.
    Fang YP; Chang CC; Lai W; Lee CY
    J Microbiol Immunol Infect; 2024 Aug; 57(4):564-572. PubMed ID: 38937186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominance of ON1 and BA9 genotypes of respiratory syncytial virus (RSV) in Bulgaria, 2016-2018.
    Korsun N; Angelova S; Trifonova I; Voleva S; Grigorova I; Tzotcheva I; Mileva S; Alexiev I; Perenovska P
    J Med Virol; 2021 Jun; 93(6):3401-3411. PubMed ID: 32779756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic characterization of human respiratory syncytial virus circulating in Islamabad, Pakistan, during an outbreak in 2022-2023.
    Haider SA; Jamal Z; Tahir F; Salman M; Umair M
    Arch Virol; 2024 Apr; 169(5):106. PubMed ID: 38644429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of respiratory syncytial virus for 28 consecutive seasons (1990-2018) and genetic variability of the duplication region in the G gene of genotypes ON1 and BA in South Korea.
    Yun KW; Choi EH; Lee HJ
    Arch Virol; 2020 May; 165(5):1069-1077. PubMed ID: 32144544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials.
    Simões EAF; Madhi SA; Muller WJ; Atanasova V; Bosheva M; Cabañas F; Baca Cots M; Domachowske JB; Garcia-Garcia ML; Grantina I; Nguyen KA; Zar HJ; Berglind A; Cummings C; Griffin MP; Takas T; Yuan Y; Wählby Hamrén U; Leach A; Villafana T
    Lancet Child Adolesc Health; 2023 Mar; 7(3):180-189. PubMed ID: 36634694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nirsevimab Immunization to Prevent Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants and Children up to 24 Months of Age.
    Cieslak CM
    Nurs Womens Health; 2024 Feb; 28(1):75-79. PubMed ID: 38070539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence analysis of respiratory syncytial virus cases reveals a novel subgroup -B strain circulating in north-central Italy after pandemic restrictions.
    Pierangeli A; Midulla F; Piralla A; Ferrari G; Nenna R; Pitrolo AMG; Licari A; Marseglia GL; Abruzzese D; Pellegrinelli L; Galli C; Binda S; Cereda D; Fracella M; Oliveto G; Campagna R; Petrarca L; Pariani E; Antonelli G; Baldanti F
    J Clin Virol; 2024 Aug; 173():105681. PubMed ID: 38733664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children: A Systematic Review and Network Meta-analysis.
    Sun M; Lai H; Na F; Li S; Qiu X; Tian J; Zhang Z; Ge L
    JAMA Netw Open; 2023 Feb; 6(2):e230023. PubMed ID: 36800182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary analysis of the ON1 genotype of subtype a respiratory syncytial virus in Riyadh during 2008-16.
    Al-Hassinah S; Parveen S; Somily AM; AlSaadi MM; Alamery SF; Haq SH; Alsenaidy HA; Ahmed A
    Infect Genet Evol; 2020 Apr; 79():104153. PubMed ID: 31881360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic characterization respiratory syncytial virus in Kerala, the southern part of India.
    Patil SL; Balakrishnan A
    J Med Virol; 2017 Dec; 89(12):2092-2097. PubMed ID: 28464224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and viral loads of respiratory syncytial virus in hospitalized children prior to and during COVID-19 pandemic in Hangzhou, China.
    Chen Y; Zhao X; Ye C; Zhou J; Wang J; Ye X
    J Med Virol; 2024 Aug; 96(8):e29855. PubMed ID: 39119991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.